XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 4,542 $ 4,872
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Investment related (gains) losses on sale of investments and other assets (963) 288
Net deferred policy acquisition cost (4,293) (2,544)
Amortization of cost of insurance acquired 172 161
Depreciation 144 122
Amortization of premiums and discounts on investments 1,291 1,203
Stock-based compensation 154 70
Deferred federal income tax expense (benefit) (143) 706
Change in:    
Accrued investment income 70 173
Reinsurance recoverable (217) 237
Due premiums 1,384 2,648
Future policy benefit reserves 128 (125)
Other policyholders' liabilities 6,929 1,582
Federal income tax receivable 1,353 1,138
Commissions payable and other liabilities (1,863) (2,673)
Other, net (1,900) (504)
Net cash provided by operating activities 6,788 7,354
Cash flows from investing activities:    
Purchases of fixed maturity securities, available-for-sale (23,271) (25,114)
Sales of fixed maturity securities, available-for-sale 2,508 2,865
Maturities and calls of fixed maturity securities, available-for-sale 12,366 14,426
Principal payments on mortgage loans 3 2
(Increase) decrease in policy loans, net 85 114
Sales of other long-term investments 82 249
Purchases of other long-term investments (1,181) (3,495)
Purchase of property and equipment (58) (73)
Net cash used in investing activities (9,466) (11,026)
Cash flows from financing activities:    
Annuity deposits 1,600 2,008
Annuity withdrawals (2,650) (2,365)
Other (27) (20)
Net cash used in financing activities (1,077) (377)
Net decrease in cash and cash equivalents (3,755) (4,049)
Cash and cash equivalents at beginning of year 26,997 22,973
Cash and cash equivalents at end of period $ 23,242 $ 18,924